Express Healthcare
Home  »  News  »  Deloitte develops digital accelerator to help healthcare systems, communities address COVID-19 crisis

Deloitte develops digital accelerator to help healthcare systems, communities address COVID-19 crisis

0 479
Read Article

The accelerator is designed to support remote patient intake process, including ability to guide locations of care

In response to the global spread of the novel coronavirus, Deloitte has developed an accelerator that is part of its ConvergeHEALTH Connect suite, designed to enable national health authorities, health systems, and other organisations to digitally triage and manage the treatment of COVID-19 patients, as well as support the care and remote monitoring of quarantined or convalescing patients to further contain the spread.

The ConvergeHEALTH Connect for Crisis Response accelerator is a new pandemic response offering built on the Salesforce Health Cloud platform. It includes an innovative AI-based triage tool and clinical prediction technology by Diagnostics Robotics, hosted on Google Cloud.

“Deloitte is committed to doing all we can to help flatten the curve, which is why we’ve joined forces with Salesforce, Google and Diagnostic Robotics to enable healthcare systems to more effectively triage decisions about treating and managing the spread of the coronavirus,” said Punit Renjen, CEO, Deloitte Global. “Building on the ConvergeHEALTH Connect platform, which supports patients around the globe, Deloitte has moved quickly to develop this new digital accelerator specifically tailored to COVID-19.”

ConvergeHEALTH Connect for Crisis Response supports healthcare systems and organisations as they activate their local systems’ medical care treatment plans. The offering provides dashboards and also allows health care systems and organisations to provide patients with real-time updates during the treatment process. This accelerator is designed to support the remote patient intake process, including the ability to guide locations of care (e.g., at a facility versus at home). The accelerator also helps identify individuals from whom and locations where a patient could have been exposed to the virus.

The accelerator has been deployed first in the Indian state of Odisha to help protect the people in the state, and the data will be used by their command centre. Customised to the specific needs in India, the solution includes:

  • A self-assessment questionnaire that can be accessed through the state government portal. Upon completion of the questionnaire, a risk rating and guidance will be produced for each participant; and
  • WhatsApp accessibility, which will be rolled out in the coming days, to facilitate increased use, including by migrant workers, which is crucial as the economy begins to open back up in the weeks ahead.

In the coming weeks the accelerator will be made available in several other geographies.

The accelerator is supported by a unified, reliable, and secure infrastructure for real-time data analysis and insights. Its main capabilities include:

  • For healthcare systems: Provides AI-based smart digital triage; central national / regional infrastructure for treatment of mildly ill patients and those under quarantine; supports incorporation and management of treatment plans and distribution based on a unified protocol; and real-time national documentation, monitoring and identification of patients, people under quarantine, and possible exposures. 
  • For medical teams: Provides management support of client-provided medical care plans based on a unified protocol; support of remote treatment using digital medical tools and the ability to manage quarantined medical teams remotely; synchronisation and transparency of data between patients and their medical professionals; and updates regarding, for example, lab results or change in health status.
  • For patients: Empowers patients during treatment through the use of digital tools; provides remote knowledge sharing, communication, and support for the patient and patient’s family with the distribution of relevant content and guidelines.

Renjen added, “The COVID-19 pandemic is an unprecedented global public health crisis requiring everyone to step in and help. Deloitte is bringing full power and expertise to help accelerate effective solutions and tools that can be used to combat COVID-19.”

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More